Kristin Lindstrom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kristin Lindstrom has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Superti-Furga
Division of Genetic Medicine, University of Lausanne, Lausanne, Switzerland
1 shared publication - Aneta Kaczmarczyk
Department of Pathology, University of Utah, Salt Lake City, UT, USA
1 shared publication - Belinda Campos-Xavier
Division of Genetic Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland
1 shared publication Caroline Eggerding
Cooper University Health Care, Camden, NJ, USA
1 shared publication- Christine Umandap
Medical Genetics, DMG Children’s Rehabilitative Services, Phoenix, AZ 85013, USA
1 shared publication - Danielle Starin
Rare Disease Institute, Children's National, Washington, DC, USA
1 shared publication
Latest Publications
- Open Access
- 16 March 2022
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 31, 100857
A neonate with ornithine aminotransferase deficiency; insights on the hyperammonemia-associated biochemical phenotype of gyrate atrophy
- 16 March 2022
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 31, 100857
Open AccessA neonate with ornithine aminotransferase deficiency; insights on the hyperammonemia-associated biochemical phenotype of gyrate atrophy
- Open Access
Clinical and Molecular Diagnosis of Osteocraniostenosis in Fetuses and Newborns: Prenatal Ultrasound, Clinical, Radiological and Pathological Features
Osteocraniostenosis (OCS, OMIM #602361) is a severe, usually lethal condition characterized by gracile bones with thin diaphyses, a cloverleaf-shaped skull and splenic hypo/aplasia. The condition is caused by heterozygous mutations in the FAM111A gene and is allelic to the non-lethal, dominant disorder Kenny-Caffey syndrome (KCS, OMIM #127000). Here we report two new cases of OCS, including one with a detailed pathological examination. We review the main diagnostic signs of OCS both before and after birth based on our observations and on the literature. We then review the current knowledge on the mutational spectrum of FAM111A associated with either OCS or KCS, including three novel variants, both from one of the OCS fetuses described here, and from further cases diagnosed at our centers. This report refines the previous knowledge on OCS and expands the mutational spectrum that results in either OCS or KCS.
Open AccessClinical and Molecular Diagnosis of Osteocraniostenosis in Fetuses and Newborns: Prenatal Ultrasound, Clinical, Radiological and Pathological Features
Osteocraniostenosis (OCS, OMIM #602361) is a severe, usually lethal condition characterized by gracile bones with thin diaphyses, a cloverleaf-shaped skull and splenic hypo/aplasia. The condition is caused by heterozygous mutations in the FAM111A gene and is allelic to the non-lethal, dominant disorder Kenny-Caffey syndrome (KCS, OMIM #127000). Here we report two new cases of OCS, including one with a detailed pathological examination. We review the main diagnostic signs of OCS both before and after birth based on our observations and on the literature. We then review the current knowledge on the mutational spectrum of FAM111A associated with either OCS or KCS, including three novel variants, both from one of the OCS fetuses described here, and from further cases diagnosed at our centers. This report refines the previous knowledge on OCS and expands the mutational spectrum that results in either OCS or KCS.
- Open Access
- 14 August 2021
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 28, 100790
Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics
- 14 August 2021
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 28, 100790
Open AccessUse of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics